scholarly journals Retrospective Genotyping and Whole Genome Sequencing of a Canine Parvovirus Outbreak in Bangladesh

Pathogens ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 1373
Author(s):  
Tofazzal Md Rakib ◽  
Babu Kanti Nath ◽  
Tridip Das ◽  
Saroj Kumar Yadav ◽  
Shane R. Raidal ◽  
...  
Keyword(s):  
Clinical Signs ◽  
Case Fatality ◽  
Canine Parvovirus ◽  
Whole Genome ◽  
High Resolution Melt ◽  
Southeastern Part ◽  
Antigenic Variant ◽  
Whole Genome Shotgun Sequencing ◽  
Canine Population ◽  
Polymerase Chain

Canine parvovirus 2 (CPV-2) outbreaks in close quarters such as kennels or shelters can cause substantial case fatality. Thirteen dead Labradors from a secluded kennel of security dogs presented with typical clinical signs and gross pathology of parvovirus infection. Whole genome shotgun sequencing from tissue-extracted genomic DNA detected new CPV-2a as the contributing antigenic variant. Further genotyping using polymerase chain reaction coupled with high-resolution melt assays (PCR-HRM) confirmed new CPV-2a infection in all deceased dogs. PCR-HRM of additional thirty-four clinically suspected dogs suggested that this variant is in wider community circulation, at least in the southeastern part of Bangladesh. We present complete genome sequence of the new CPV-2a variant circulating in the domestic canine population of Bangladesh.

scholarly journals Comparison of Three Rapid Commercial Canine Parvovirus Antigen Detection Tests with Electron Microscopy and Polymerase Chain Reaction

2009 ◽  
Vol 21 (3) ◽  
pp. 344-345 ◽  
Author(s):  
Silke Schmitz ◽  
Christina Coenen ◽  
König Matthias ◽  
Thiel Heinz-Jürgen ◽  
Reto Neiger
Keyword(s):  
Electron Microscopy ◽  
Polymerase Chain Reaction ◽  
Chronic Diarrhea ◽  
Gastrointestinal Disease ◽  
Clinical Signs ◽  
Canine Parvovirus ◽  
Chain Reaction ◽  
Group A ◽  
Polymerase Chain ◽  
Group B

Different antibody-based tests for rapid detection of Canine parvovirus antigens in feces are commercially available, allowing quick diagnosis in a clinical setting. However, the diagnostic accuracy of these tests compared with standard methods has not been evaluated so far. In the current study, 3 commercial tests were compared with immune-electron microscopy (IEM) and polymerase chain reaction (PCR). Dogs were divided into 3 groups: group A, samples from dogs with acute hemorrhagic diarrhea ( n = 50); group B, dogs with chronic diarrhea ( n = 10); and group C, dogs with no evidence of gastrointestinal disease ( n = 40). Specificity of all 3 commercial tests versus PCR and IEM was good to excellent (92.2–100%). Sensitivity, in contrast, was poor: 15.8–26.3% versus PCR and 50–60% versus IEM. In group A, 10 dogs were positive by IEM and 24 dogs were positive by PCR. Positive PCR results were also obtained from animals in control groups (group B, 1 dog; group C, 5 dogs). No dog in group B or C was positive by IEM. In conclusion, the rapid tests are useful to diagnose canine parvoviral enteritis, but they do not rule out parvovirus infection in an animal with typical clinical signs. In addition, a small percentage of healthy dogs and dogs with chronic diarrhea showed positive PCR results; this may be due to asymptomatic/persistent infection or intestinal passage of virus. The significance of this finding remains unclear.

scholarly journals Dynamic evolution of canine parvovirus in Thailand

2020 ◽  
Vol 13 (2) ◽  
pp. 245-255
Author(s):  
N. Inthong ◽  
S. Kaewmongkol ◽  
N. Meekhanon ◽  
K. Sirinarumitr ◽  
T. Sirinarumitr
Keyword(s):  
Amino Acids ◽  
Clinical Signs ◽  
Canine Parvovirus ◽  
Specific Primers ◽  
Highly Pathogenic ◽  
Vp2 Gene ◽  
Fecal Samples ◽  
Feline Panleukopenia Virus ◽  
Close Relationship ◽  
Polymerase Chain

Background and Aim: According to the previous study, the circulating canine parvovirus (CPV) in Thailand is 2a and 2b. Nowadays, CPV mutants, including CPV-2c, have been identified in many parts of the world. This study aimed to investigate the genetic diversity of the circulating CPV in Thailand. Materials and Methods: Eighty-five CPV-positive fecal samples were obtained from dogs with either acute hemorrhagic diarrhea or diarrhea. The complete VP2 gene of these samples was amplified using VP2 specific primers and polymerase chain reaction (PCR). The obtained full-length VP2 sequences were analyzed and a phylogenetic tree was constructed. Results: Sixty and 25 CPV-positive fecal samples were collected in 2010 and 2018, respectively. Thirty-four samples were new CPV-2a and 31 samples were new CPV-2b due to amino acids substitution at position 297 (Ser-Ala). In 2018, 5 new CPV-2a, 19 CPV-2c, and 1 feline panleukopenia virus (FPV) were found, but no new CPV-2b was detected. Moreover, most of the CPV in this study had amino acids mutations at positions 324 and 440. The phylogenetic construction demonstrated the close relationship between the current new CPV-2a with the previous CPV-2a reported from Thailand, China, Uruguay, Vietnam, Singapore, and India. Interestingly, the current new CPV-2b in this study was not closely related to the previous CPV-2b reported in Thailand. The CPV-2c in this study was closer to Asian CPV-2c and further from either European or South America CPV-2c. Interestingly, FPV was identified in a diarrhea dog. Conclusion: The evolution of CPV in Thailand is very dynamic. Thus, it is important to monitor for CPV mutants and especially the clinical signs relating to these mutants to conduct surveillance for the emergence of new highly pathogenic CPV in the future.

Occurrence of Canine parvovirus-2 and Canine adenovirus-1 Infections in Dogs: A Hospital Based Study

2020 ◽  
Author(s):  
G.E. Chethan ◽  
Mithilesh Singh ◽  
Vishal Chander ◽  
Akhilesh . ◽  
Degpal Singh ◽  
...  
Keyword(s):  
Sequential Analysis ◽  
Canine Parvovirus ◽  
Control Measures ◽  
Antigenic Variant ◽  
Study Region ◽  
Northern India ◽  
Enteric Diseases ◽  
Faecal Samples ◽  
Polymerase Chain ◽  
Very High

Canine parvovirus-2 (CPV-2) and canine adenovirus-1 (CAV-1) are the major viral agents causing enteric diseases in dogs worldwide despite several control measures. The objective of the present study was to investigate the hospital based occurrence of CPV-2 and CAV-1 in dogs in teaching veterinary clinical complex of northern India from August, 2017 to March, 2019. Faecal samples were collected from the dogs with gastroenteritis and screened for CPV-2 and CAV-1 infections by polymerase chain reaction (PCR). Simultaneously, data regarding age, breed, sex and vaccination status were also recorded from the affected dogs. A total of 216 faecal samples were collected during the study period out of which 90 (41.67%), 12 (5.56%) and 26 (12.04%) samples were found to be positive for CPV-2, CAV-1 and co-infection, respectively. The analysis of positive samples revealed that the occurrence of CPV-2 and CAV-1 infection was highest in young dogs of the age group 0-3 months (CPV-2=44.44% and CAV-1=33.33%), Labrador Retriever breed (CPV-2=35.55% and CAV-1=50.0%) and unvaccinated dogs (CPV-2=68.88% and CAV-1=83.33%). Sex wise analysis revealed that the positivity of CPV-2 infection was higher in female (51.11%) than male dogs (48.88%) but, no such difference was noticed with respect to CAV-1 infection. It is concluded that the occurrence of CPV-2 and CAV-1 infections was very high in the study region and proper control measures are recommended. However, analysis of large number of samples including those from the field are required for further validation of the study as well as sequential analysis of CPV-2 to ensure the prevalent field antigenic variant of CPV-2 in the region. 

scholarly journals Clinical and Virological Findings in Pups Naturally Infected by Canine Parvovirus Type 2 Glu-426 Mutant

2005 ◽  
Vol 17 (2) ◽  
pp. 133-138 ◽  
Author(s):  
Nicola Decaro ◽  
Costantina Desario ◽  
Marco Campolo ◽  
Gabriella Elia ◽  
Vito Martella ◽  
...  
Keyword(s):  
Real Time ◽  
Virus Isolation ◽  
Clinical Signs ◽  
Canine Parvovirus ◽  
Viral Shedding ◽  
Polymerase Chain ◽  
Loss Of Appetite ◽  
Hematological Changes ◽  
Canine Parvovirus Type 2

An outbreak of canine parvovirus type 2 infection caused by the Glu-426 mutant in 2 litters of pups is reported. The infected pups ( n = 6) were monitored daily for evidence of clinical signs and hematological changes and for the evaluation of viral shedding in the feces. The disease induced by the Glu-426 mutant was mild in all the infected pups. Vomiting and hemorrhagic diarrhea were not observed; however, the pups developed mucoid diarrhea (3.5 median days), depression (1.5 median days), and relative leukopenia and lymphopenia (2.5 median days). Fever and loss of appetite were observed only in 2 pups. Virus was detected in the feces for 4.5, 6.5, and 46 median days by hemagglutination, virus isolation on cell cultures, and real-time polymerase chain reaction (PCR), respectively. By real-time PCR, the highest viral DNA titers were detected in the feces of both litters at day 10, reaching median values of more than 1010 DNA copies/mg of feces.

scholarly journals The detection of canine parvovirus type 2c of Asian origin in dogs in Romania evidenced its progressive worldwide diffusion

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Andrea Balboni ◽  
Mihaela Niculae ◽  
Serena Di Vito ◽  
Lorenza Urbani ◽  
Alessia Terrusi ◽  
...  
Keyword(s):  
Amino Acid ◽  
Acute Gastroenteritis ◽  
Clinical Signs ◽  
Canine Parvovirus ◽  
Amino Acid Residues ◽  
Asian Origin ◽  
Vp2 Gene ◽  
Faecal Samples ◽  
Canine Population ◽  
Pcr Targeting

Abstract Background Canine parvovirus (CPV) is one of the most important pathogens of dogs. Despite vaccination, CPV infections are still ubiquitous in dogs, and the three antigenic variants 2a, 2b and 2c are variously distributed in the canine population worldwide. To date, no information is available on CPV variants circulating in some European countries. The aim of this study was to genetically characterise the CPV detected in ten dogs with clinical signs of acute gastroenteritis in Romania. The presence of Carnivore protoparvovirus 1 DNA was investigated in faecal samples using an end-point PCR targeting the complete VP2 gene and positive amplicons were sequenced and analysed. Results All ten dogs with acute gastroenteritis tested positive to Carnivore protoparvovirus 1 DNA in faecal samples. The identified viruses belonged to CPV-2c type, showed identical sequences of the VP2 gene and were characterised by distinctive amino acid residues in the deduced VP2 protein: 5-glicine (5Gly), 267-tirosine (267Tyr), 324-isoleucine (324Ile) and 370-arginine (370Arg). These distinctive amino acid residues have already been reported in CPV-2c widespread in Asia and occasionally detected in Italy and Nigeria. Conclusions Since CPV-2c with VP2 amino acid residues 5Gly, 267Tyr, 324Ile and 370Arg were never reported before 2013, it can be assumed that this virus is progressively expanding its spread in the world dog population. This study adds new data about the presence of this new virus in Europe and underline worrying questions about its potential impact on the health of the canine population.

scholarly journals Increased survival in puppies affected by Canine Parvovirus type II using an immunomodulator as a therapeutic aid

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Adriana I. Muñoz ◽  
Luis Vallejo-Castillo ◽  
Ana Fragozo ◽  
Said Vázquez-Leyva ◽  
Lenin Pavón ◽  
...  
Keyword(s):  
Critical Period ◽  
Clinical Status ◽  
Clinical Signs ◽  
Cell Receptor ◽  
Clinical Findings ◽  
Canine Parvovirus ◽  
Type Ii ◽  
Cell Parameters ◽  
Hospitalization Period ◽  
Polymerase Chain

AbstractCanine parvovirus type II (CPV-2) infection induces canine parvoviral enteritis (CPE), which in turn promotes sepsis and systemic inflammatory response syndrome (SIRS). Mortality in this disease is usually registered within 48–72 h post-hospitalization, the critical period of the illness. It has been recently described that the use of an immunomodulator, whose major component is monomeric ubiquitin (mUb) without the last two glycine residues (Ub∆GG), in pediatric human patients with sepsis augments survival. It is known that CXCR4 is the cell receptor of extracellular ubiquitin in humans. This work aimed to explore the effect of one immunomodulator (human Dialyzable Leukocyte Extract-hDLE) as a therapeutic auxiliary in puppies with sepsis and SIRS induced by CPE. We studied two groups of puppies with CPV-2 infection confirmed by polymerase chain reaction. The first group received conventional treatment (CT) and vehicle (V), while the second group received CT plus the immunomodulator (I). We assessed both groups' survival, clinical condition, number of erythrocytes, neutrophils, and lymphocytes during the hospitalization period. In addition, hematocrit, hemoglobin, plasma proteins and cortisol values, as well as norepinephrine/epinephrine and serotonin concentration were determined. Puppies treated with CT + I showed 81% survival, mild clinical signs, and a significant decrease in circulating neutrophils and lymphocytes in the critical period of the treatment. In contrast, the CT + V group presented a survival of 42%, severe clinical status, and no improvement of the parameters evaluated in the critical period of the disease. We determined in silico that human Ub∆GG can bind to dog CXCR4. In conclusion, the administration of a human immunomodulator (0.5 mg/day × 5 days) to puppies with CPE under six months of age reduces the severity of clinical signs, increases survival, and modulates inflammatory cell parameters. Further studies are necessary to take full advantage of these clinical findings, which might be mediated by the human Ub∆GG to canine CXCR4 interaction.

scholarly journals Investigation on Canine parvovirus circulation in dogs from Sicily (Italy) by biomolecular assay

2018 ◽  
Vol 68 (1) ◽  
pp. 80-94 ◽  
Author(s):  
Purpari Giuseppa ◽  
Mira Francesco ◽  
Di Bella Santina ◽  
Di Pietro Simona ◽  
Giudice Elisabetta ◽  
...  
Keyword(s):  
Field Isolate ◽  
Canine Parvovirus ◽  
Vp2 Gene ◽  
Worldwide Distribution ◽  
High Prevalence ◽  
Canine Population ◽  
Close Relationship ◽  
Polymerase Chain ◽  
Canine Parvovirus Type 2

Abstract Canine parvovirus type-2 (CPV-2) is a DNA virus that causes a very common worldwide diffused infectious disease in dogs. Since its appearance, the CPV-2 evolved generating novel genetic and antigenic variants (CPV-2a/2b/2c) which are distributed throughout the world. In the present study, the frequency of CPV-2 in a canine population in Sicily (Italy) was investigated, using a polymerase chain reaction (PCR) for a fragment of the VP2 gene. Out of a total of 673 samples from 370 dogs, submitted to the laboratory from July 2009 to August 2015, 265 samples (39.38%) were positive and these were further analyzed by restriction fragment length polymorphism (RFLP) and DNA sequence analysis. A high prevalence of the CPV-2c variant (79.56% of CPV-2 positive dogs) was observed in this survey, underlining that this type of CPV field isolate is prevalent circulating in Sicily. Sequence and phylogenetic analysis showed a close relationship with CPV-2a and CPV-2c strains from Europe and non-European countries. Considering that CPV-2c is reaching a worldwide distribution and that this variant is also affecting vaccinated dogs, efforts should be made towards the development of new CPV vaccines.

scholarly journals Phylogenetic characterization of Canine Parvovirus VP2 partial sequences from symptomatic dogs samples

2016 ◽  
Vol 19 (1) ◽  
pp. 187-196 ◽  
Author(s):  
D. Zienius ◽  
R. Lelešius ◽  
H. Kavaliauskis ◽  
A. Stankevičius ◽  
A. Šalomskas
Keyword(s):  
Sequence Similarity ◽  
Canine Parvovirus ◽  
Chain Reaction ◽  
Antigenic Variant ◽  
Vp2 Gene ◽  
Phylogenetic Characterization ◽  
Faecal Samples ◽  
Polymerase Chain ◽  
The One

Abstract The aim of the present study was to detect canine parvovirus (CPV) from faecal samples of clinically ill domestic dogs by polymerase chain reaction (PCR) followed by VP2 gene partial sequencing and molecular characterization of circulating strains in Lithuania. Eleven clinically and antigen-tested positive dog faecal samples, collected during the period of 2014-2015, were investigated by using PCR. The phylogenetic investigations indicated that the Lithuanian CPV VP2 partial sequences (3025-3706 cds) were closely related and showed 99.0-99.9% identity. All Lithuanian sequences were associated with one phylogroup, but grouped in different clusters. Ten of investigated Lithuanian CPV VP2 sequences were closely associated with CPV 2a antigenic variant (99.4% nt identity). Five CPV VP2 sequences from Lithuania were related to CPV-2a, but were rather divergent (6.8 nt differences). Only one CPV VP2 sequence from Lithuania was associated (99.3% nt identity) with CPV-2b VP2 sequences from France, Italy, USA and Korea. The four of eleven investigated Lithuanian dogs with CPV infection symptoms were vaccinated with CPV-2 vaccine, but their VP2 sequences were phylogenetically distantly associated with CPV vaccine strains VP2 sequences (11.5-15.8 nt differences). Ten Lithuanian CPV VP2 sequences had monophyletic relations among the close geographically associated samples, but five of them were rather divergent (1.0% less sequence similarity). The one Lithuanian CPV VP2 sequence was closely related with CPV-2b antigenic variant. All the Lithuanian CPV VP2 partial sequences were conservative and phylogenetically low associated with most commonly used CPV vaccine strains.

THE 2019 NOVEL PANDEMIC OF CORONAVIRUS DISEASE (COVID-19): A STUDY OF EXISTING EVIDENCE IN THE INDIAN POPULATION

2020 ◽  
Vol 7 (2) ◽  
pp. 199-204
Author(s):  
Shrikant Verma ◽  
Mohammad Abbas ◽  
Sushma Verma ◽  
Syed Tasleem Raza ◽  
Farzana Mahdi
Keyword(s):  
Disease Transmission ◽  
Indian Population ◽  
Respiratory Infections ◽  
Clinical Signs ◽  
Case Fatality ◽  
Public Health Emergency ◽  
The World ◽  
And Control ◽  
General Wellbeing ◽  
Different Parts

A novel spillover coronavirus (nCoV), with its epicenter in Wuhan, China's People's Republic, has emerged as an international public health emergency. This began as an outbreak in December 2019, and till November eighth, 2020, there have been 8.5 million affirmed instances of novel Covid disease2019 (COVID-19) in India, with 1,26,611 deaths, resulting in an overall case fatality rate of 1.48 percent. Coronavirus clinical signs are fundamentally the same as those of other respiratory infections. In different parts of the world, the quantity of research center affirmed cases and related passings are rising consistently. The COVID- 19 is an arising pandemic-responsible viral infection. Coronavirus has influenced huge parts of the total populace, which has prompted a global general wellbeing crisis, setting all health associations on high attentive. This review sums up the overall landmass, virology, pathogenesis, the study of disease transmission, clinical introduction, determination, treatment, and control of COVID-19 with the reference to India.

Sign in / Sign up

Export Citation Format

Share Document